Level Chart

Basic Info

Eli Lilly & Co (LLY) - Neuroscience Revenue is at a current level of 1.391B, down from 1.473B one year ago. This is a change of -5.59% from one year ago.

Neuroscience Revenue refers to the total revenue generated by Eli Lilly & Co from its products and treatments related to neuroscience within a specific reporting period.

Region United States
Source Fiscal.ai

Data provided via Fiscal.ai

Stats

Last Value 1.391B
Latest Period 2025
Last Updated Feb 15 2026, 08:32 EST
Next Release Feb 15 2027, 08:30 EST (E)
Average Growth Rate -7.63%
Value from 1 Year Ago 1.473B
Change from 1 Year Ago -5.59%
Frequency Yearly
Unit USD
Adjustment N/A
Download Source File

Historical Data

View and export this data back to 2012. Upgrade now.
Date Value
December 31, 2025 1.391B
December 31, 2024 1.473B
December 31, 2023 2.878B
December 31, 2022 1.546B
December 31, 2021 1.898B
December 31, 2020 1.831B
December 31, 2019 1.723B
Date Value
December 31, 2018 1.821B
December 31, 2017 2.171B
December 31, 2016 2.720B
December 31, 2015 2.935B
December 31, 2014 3.596B
December 31, 2013 7.216B
December 31, 2012 7.575B

Basic Info

Eli Lilly & Co (LLY) - Neuroscience Revenue is at a current level of 1.391B, down from 1.473B one year ago. This is a change of -5.59% from one year ago.

Neuroscience Revenue refers to the total revenue generated by Eli Lilly & Co from its products and treatments related to neuroscience within a specific reporting period.

Region United States
Source Fiscal.ai

Data provided via Fiscal.ai

Stats

Last Value 1.391B
Latest Period 2025
Last Updated Feb 15 2026, 08:32 EST
Next Release Feb 15 2027, 08:30 EST (E)
Average Growth Rate -7.63%
Value from 1 Year Ago 1.473B
Change from 1 Year Ago -5.59%
Frequency Yearly
Unit USD
Adjustment N/A
Download Source File

Related Securities

Symbol Name Change %
LLY Eli Lilly & Co. 0.62%